Invention Grant
- Patent Title: Substituted pyrimidine kinase inhibitors
- Patent Title (中): 取代的嘧啶激酶抑制剂
-
Application No.: US11690305Application Date: 2007-03-23
-
Publication No.: US08013153B2Publication Date: 2011-09-06
- Inventor: Jeannene Butler , Peter J. Connolly , Angel R. Fuentes-Pesquera , Lee M. Greenberger , Shenlin Huang , Kenneth R. LaMontagne, Jr. , Ronghua Li , Guozhang Xu
- Applicant: Jeannene Butler , Peter J. Connolly , Angel R. Fuentes-Pesquera , Lee M. Greenberger , Shenlin Huang , Kenneth R. LaMontagne, Jr. , Ronghua Li , Guozhang Xu
- Applicant Address: BE Beerse
- Assignee: Janssen Pharmaceutica, N.V.
- Current Assignee: Janssen Pharmaceutica, N.V.
- Current Assignee Address: BE Beerse
- Agency: Johnson & Johnson
- Agent Rajiv Shah, Esquire
- Main IPC: C07D403/12
- IPC: C07D403/12 ; C07D403/14 ; A61K31/506 ; A61P19/02
Abstract:
The present invention is directed to substituted pyrimidine compounds of formula (I): and forms thereof, their synthesis and use for treating a chronic or acute protein kinase mediated disease, disorder or condition.
Public/Granted literature
- US20070254896A1 SUBSTITUTED PYRIMIDINE KINASE INHIBITORS Public/Granted day:2007-11-01
Information query
